LC determination of the diastereomers of 1-(beta-D-glucopyranosyl)phenobarbital in human urine

J Pharm Biomed Anal. 1990;8(4):365-72. doi: 10.1016/0731-7085(90)80051-p.

Abstract

The "product enantioselectivity" associated with the urinary excretion of the phenobarbital N-glucoside conjugates has not been determined previously. A liquid chromatography method using gradient elution was developed for quantifying both phenobarbital N-glucoside conjugates, phenobarbital, and p-hydroxyphenobarbital. Following a single oral dose of phenobarbital to male Caucasian and Oriental subjects, both phenobarbital N-glucoside conjugates were observed in the urine. In seven subjects, 3.3-10.6% of the phenobarbital dose was detected as a single phenobarbital N-glucoside (S configuration at the C-5 position of the barbiturate ring). The other phenobarbital N-glucoside diastereomer accounted for less than 1.5% of the phenobarbital dose. The urinary excretion of the major phenobarbital N-glucoside diastereomer paralleled the urinary excretion of phenobarbital and was comparable in both Caucasian and Oriental subjects. These results indicate a pronounced selectivity for the formation and/or urinary excretion of the phenobarbital N-glucosides.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Asian People
  • Chromatography, Liquid / methods
  • Humans
  • Phenobarbital / analogs & derivatives*
  • Phenobarbital / pharmacokinetics
  • Phenobarbital / urine
  • Stereoisomerism
  • White People

Substances

  • 4-hydroxyphenobarbital
  • phenobarbital-N-glucoside
  • Phenobarbital